Source: Annual Congress 2013 –Difficult and rare respiratory infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Gerogianni, C. Neocleous, K. Gourgoulianis, E. Petinaki (Larisa, Greece). Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia. Eur Respir J 2013; 42: Suppl. 57, 2079

Member's Comments

No comment yet.

Related content which might interest you: Bacterial community-acquired pneumonia Source: Eur Respir Monogr 2014; 66: 98-111 Year: 2014 Bacterial infections and community-acquired pneumonia in children Source: Annual Congress 2011 - Paediatric Year in Review Year: 2011 Multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia Source: Annual Congress 2013 –Recent developments in pneumonia Year: 2013 The effect of macrolide-resistance on the outcome of patients hospitalized for streptococcus pneumoniae pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Bacteraemia in outpatients with community-acquired pneumonia Source: Eur Respir J 2016; 47: 654-657 Year: 2016 Predictors of treatment failure in patients with bacteremic pneumococcal community-acquired pneumonia Source: Annual Congress 2013 –Pneumonia and sepsis Year: 2013 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Are there differences in Pneumonia sp. pneumoniae in patients with community-acquired pneumonia patients and institutionalized? Source: Annual Congress 2009 - Pulmonary infections Year: 2009 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Epidemiology of community-acquired pneumonia and nosocomial pneumonia Source: Annual Congress 2006 - PG1 - Respiratory infections: pneumonia/antibiotic resistance and clinical outcome of lower respiratory tract infections Year: 2006 Carbapenem-resistant pathogens in US patients hospitalized with respiratory infections Source: International Congress 2018 – Clinical challenges in respiratory infection Year: 2018 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004 MRSA as a cause of community-acquired pneumonia Source: Eur Respir J 2009; 34: 1013-1014 Year: 2009 Multidrug-resistant bacteria in community-acquired pneumonia Source: International Congress 2017 – PG17 Infectious disease challenges in community-acquired pneumonia and tuberculosis: improving your clinical practice Year: 2017 The lung bacterial microbiome in community-acquired and nosocomial pneumonia Source: Eur Respir Monogr 2019; 83: 188-194 Year: 2019 Changes in pathogens and pneumococcal serotypes causing community-acquired pneumonia in The Netherlands Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Bacteremic vs. non-bacteremic pneumococcal pneumonia in immunocompetent patients: Predictive and prognostic factors Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Role of viruses, alone and in association with bacteria, in adults hospitalized with community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia Year: 2011 Etiological spectrum of hospitalized community-acquired pneumonia Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host Year: 2007